ISSN: 2250-0359 Volume 3 Issue 2 2013 Malignant growth Maxilla management an analysis *Balasubramanian Thiagarajan *Geetha Ramamoorthy *Stanley Medical College Abstract: Malignant tumors involving maxilla is rather rare. This comprises about 1% of all malignant tumors seen in humans. This tumor constitutes roughly 3% of all head and neck malignancies. This article discusses our experience in managing patients with malignant tumors of maxilla. All our patients underwent total maxillectomy followed by post operative irradiation. Mean survival rates of our patients ranged from 2.5 years to 3 years. Survival rates were also dependent on the histology of the tumor. This is a retrospective study of patients who presented to our Institution between 2006-2010. In our study we found that surgery had a definitive role despite the staging. Even advanced cases had a definite improvement in the quality of life. All our patients received post operative irradiation (full course) following total maxillectomy. Introduction: Malignant tumors of nose and paranasal sinuses constitute about 1% of all malignant tumors 1 . These tumors also constitute about 3% of head and neck malignancies. Malignant tumors of maxilla are more common in males infact twice as common as in females. They are commonly diagnosed in patients in the age group of 50 – 70 years 2 . Histologically the commonest type of malignancy in this area is squamous cell carcinoma 3 . Other histological types like adenocarcinoma, sarcomas, neuroblastomas, lymphomas and malignant melanomas are rare 4 . These tumors are very difficult to treat because: 1. Of the complex adjacent anatomy (orbit, skull base etc) 2. These patients present fairly in the late stage of their disease The aim of this paper is to study patients with malignant tumors of maxilla who underwent treatment at Stanley Medical College Chennai India during 2006-2010.